AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution
2024 · Nature · 52 citations
https://doi.org/10.1038/s41586-024-08031-6
A
Anjana Krishnan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
62
Citations
2
h-index
2
i10-index
Anjana Krishnan is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Genomics and Diagnostics & Advanced Breast Cancer Therapies. The author has an h-index of 2, co-authored 10 publications.
Papers by this author
worksSupplementary Figure S5 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS<i>-</i>Mutant Colorectal Cancers
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27938792
Supplementary Figure S1 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS<i>-</i>Mutant Colorectal Cancers
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27938804
Supplementary Figure S7 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS<i>-</i>Mutant Colorectal Cancers
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27938786
Supplementary Figure S2 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS<i>-</i>Mutant Colorectal Cancers
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27938801
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat